Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elizabeth Blair Solow"'
Autor:
Molly Keebler, Sandra B. Chapman, Valerie F. Reyna, Jeffrey R. Curtis, Susan J. Blalock, Elizabeth Blair Solow, Caprice Hunt, Kimberlee O’Neill, Genevieve Hickey, Delesha M. Carpenter
Publikováno v:
Arthritis Care & Research. 74:142-150
To evaluate the effectiveness of 2 interventions, including the DrugFactsBox format for presenting written medication information and the SMART (Strategic Memory Advanced Reasoning Training) program designed to enhance gist (i.e., "bottom-line" meani
Autor:
Kimberlee O’Neill, Delesha M. Carpenter, Susan J. Blalock, Jeffery Curtis, Caprice Hunt, Genevieve Hickey, Elizabeth Blair Solow, Cynthia Johnson, Cynthia Carol Edmonds, Valerie F. Reyna, Sandra B. Chapman, Molly Keebler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::84cece76630e4606e8d493546b100a97
https://doi.org/10.25302/12.2020.cdr.150227819
https://doi.org/10.25302/12.2020.cdr.150227819
Autor:
Beverley Adams-Huet, Gary Arbique, Edzard Schwedhelm, Jonathan R. Lindner, Debbie Arbique, Zhongyun Wang, Angela L Price, Alejandro Velasco, Wanpen Vongpatanasin, Elizabeth Blair Solow
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 311:H118-H124
Use of β-adrenergic receptor (AR) blocker is associated with increased risk of fatigue and exercise intolerance. Nebivolol is a newer generation β-blocker, which is thought to avoid this side effect via its vasodilating property. However, the effec
Autor:
Harlan Sayles, Bryant R. England, Lisa A. Davis, Pascale Schwab, Kaleb Michaud, Grant W. Cannon, Brian C. Sauer, Andreas M. Reimold, Elizabeth Blair Solow, Ted R. Mikuls, Gail S. Kerr, Josh F. Baker, Liron Caplan
Publikováno v:
Arthritis Care & Research. 68:36-45
Objective There has been limited investigation into cause-specific mortality and the associated risk factors in men with rheumatoid arthritis (RA). We investigated all-cause and cause-specific mortality in men with RA, examining determinants of survi
Autor:
Elizabeth Blair, Solow, Wanpen, Vongpatanasin, Brian, Skaug, David R, Karp, Colby, Ayers, James A, de Lemos
Publikováno v:
Clinical and experimental rheumatology. 36(6)
Patients with clinically evident autoimmune disease are at increased risk for premature cardiovascular disease (CVD). Markers of serological autoimmunity such as anti-nuclear antibodies (ANA) are found in approximately 25% of the general population.
Autor:
Elizabeth Blair Solow, Colby Ayers, James A. de Lemos, David R. Karp, Brian Skaug, Wanpen Vongpatanasin
Publikováno v:
Journal of the American College of Cardiology. 65(24):2669-2670
Individuals with systemic autoimmune disease exhibit a heightened risk for cardiovascular disease (CVD) [(1)][1]. Antinuclear autoantibodies (ANA) have been reported in approximately 25% of the general population [(2)][2]; yet, only a small fraction